Evexia Lifecare Ltd

Evexia Lifecare Ltd, a micro-cap player in the edible oil sector, has seen its investment rating upgraded from Strong Sell to Sell as of 9 June 2026. This change reflects a nuanced shift in the company’s valuation metrics, financial trends, and technical outlook, despite ongoing challenges in quality and long-term fundamentals. The revised Mojo Score now stands at 31.0, signalling cautious optimism amid persistent risks.

Evexia Lifecare Ltd, a micro-cap player in the edible oil sector, has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the company’s price-to-book value and other metrics suggest a nuanced change in market perception amid volatile stock performance and challenging fundamentals.

Evexia Lifecare Ltd, a micro-cap player in the edible oil sector, has seen a marked shift in its valuation parameters, moving from fair to expensive territory. Despite a recent uptick in share price, the company’s stretched price-to-earnings (P/E) ratio and other valuation metrics raise concerns about price attractiveness relative to historical levels and peer benchmarks.

Evexia Lifecare Ltd, a micro-cap player in the edible oil sector, has seen its investment rating downgraded from Sell to Strong Sell as of 27 May 2026. This shift reflects a deteriorating valuation profile, weak financial trends, and poor quality metrics despite recent positive quarterly results. The company’s lofty price multiples and underwhelming returns relative to peers and benchmarks have raised concerns among analysts and investors alike.

Evexia Lifecare Ltd, a micro-cap player in the edible oil sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change reflects evolving market perceptions amid stretched price-to-earnings and enterprise value multiples, contrasting sharply with peer averages and historical benchmarks. Investors are urged to carefully analyse these valuation dynamics alongside the company’s financial performance and sector context before making investment decisions.

Evexia Lifecare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 10 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Evexia Lifecare Ltd., a micro-cap edible oil company with a market capitalisation of ₹216.00 crores, reported a sharp turnaround in its March 2026 quarter results, posting consolidated net profit of ₹0.78 crores—a dramatic 168.97% quarter-on-quarter surge and 151.61% year-on-year growth. However, the stock continues to languish, trading at ₹1.15 on May 11, 2026, down 54.72% over the past year and reflecting persistent investor scepticism about the company's long-term viability despite the recent quarterly bounce.

Evexia Lifecare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 10 May 2026. While the rating was revised on this date, the analysis and financial metrics presented here reflect the stock's current position as of 10 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Evexia Lifecare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 April 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 29 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Evexia Lifecare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 April 2025, reflecting a reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 18 April 2026, providing investors with the latest data to understand the rationale behind this recommendation.

Evexia Lifecare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 April 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 07 April 2026, providing investors with the latest insights into the company’s performance and outlook.

After a prolonged decline spanning 16 sessions, Evexia Lifecare Ltd finally hit a fresh 52-week low of Rs 0.47 on 6 Apr 2026, marking a steep 80.69% drop over the past year. This downturn starkly contrasts with the broader market, where the Sensex remains only 2.36% above its own 52-week low despite recent weakness.

For the thirteenth consecutive session, Evexia Lifecare Ltd has closed lower, culminating in a fresh 52-week low of Rs 0.49 on 2 Apr 2026. This extended decline has wiped out over 66% of the stock’s value in less than three weeks, underscoring persistent selling pressure despite a broader market that is itself under strain but not as severely impacted.

Evexia Lifecare Ltd’s stock price reached a new 52-week low of ₹0.51 on 01 Apr 2026, marking a significant decline amid a prolonged downtrend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures within the edible oil industry and company-specific financial challenges.

Evexia Lifecare Ltd’s share price declined to a fresh 52-week low of ₹0.53 on 30 March 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock’s performance has been notably weak over the past year, reflecting a combination of financial pressures and market headwinds within the edible oil sector.